Clinical trial
Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With…
NCT00003299 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003299 |
|---|---|
| Title | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | A Randomized Phase III Study Comparing Etoposide and Cisplatin With Etoposide, Cisplatin and Paclitaxel in Patients With Extensive Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group Eastern Cooperative Oncology Group SWOG Cancer Research Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, etoposide, paclitaxel |
| Enrollment | 587 |
| Start date | Apr 1, 1998 |
| Primary completion | Jun 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Feb 20, 2004 |
| Last update posted | Jul 20, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: